Effect of legume-based DASH diet in patients with polycystic ovary syndrome

Phase 3

Conditions: polycystic ovary syndrome.
Polycystic ovarian syndrome
E28.2

Registration Number: IRCT20120913010826N33

Lead Sponsor: Research Assistant, Yazd University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 54

Inclusion Criteria

Women of reproductive age and before menopause (20-50 years)
Women with PCOS according to the Rotterdam criteria
Oligomenorrhea or amenorrhea
Clinical or laboratory hyperandrogenism

Exclusion Criteria

Pregnancy, miscarriage or breastfeeding in the last 6 months
Oligomenorrhea caused by secondary causes, including endocrine disorders (congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, adrenal disorders)
Previous history or current getting with any cancer
History of type 2 diabetes
Intrauterine Insemination (IUI) or In Vitro Fertilization) IVF(
Special diets or low-calorie diets in the past three months, including vegetarian diets

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HOMA-IR index. Timepoint: Before intervention and 16 weeks after intervention. Method of measurement: HOMA-IR = (Glu ×Insulin)/405.;Low density lipoprotein cholesterol (LDL). Timepoint: Before intervention and 16 weeks after intervention. Method of measurement: Special kit.;High density lipoprotein cholesterol (HDL). Timepoint: Before intervention and 16 weeks after intervention. Method of measurement: Special kit.;Triglyceride. Timepoint: Before intervention and 16 weeks after intervention. Method of measurement: Special kit.;Total cholesterol. Timepoint: Before intervention and 16 weeks after intervention. Method of measurement: Special kit.;FBS. Timepoint: Before intervention and 16 weeks after intervention. Method of measurement: Special kit.;Serum insulin. Timepoint: Before intervention and 16 weeks after intervention. Method of measurement: Special kit.;Free testosterone. Timepoint: Before intervention and 16 weeks after intervention. Method of measurement: Special kit.

Secondary Outcome Measures

Name	Time	Method
Weight, fat mass, fat free mass, RMR, body mass index and visceral fat. Timepoint: Before intervention and 16 weeks after the intervention. Method of measurement: Omron digital Scale.;Waist,Hip circumference. Timepoint: Before intervention and 16 weeks after the intervention. Method of measurement: Meter.;Total energy intake, total nutrients intake. Timepoint: Before intervention and 16 weeks after the intervention. Method of measurement: 24 hour recall.;The length of the menstrual cycle. Timepoint: Before intervention and 16 weeks after the intervention. Method of measurement: questionnaire.